SCHEMBL7654162

SCHEMBL7654162

CCOC(=O)c1ccc([N+](=O)[O-])cc1-c1ccccc1C(=O)Nc1ccc(C(=N)N)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 8/20 0.56
PLAU P00749 6/20 0.56
PLAT P00750 6/20 0.56
SMN1; SMN2 Q16637 4/20 0.56
ALDH1A1 P00352 4/20 0.56
GAA P10253 2/20 0.56
MEN1 O00255 4/20 0.54
KMT2A Q03164 4/20 0.54
MAPT P10636 1/20 0.54
MAPK1 P28482 1/20 0.54
F2 P00734 5/20 0.48
PRSS1 P07477 1/20 0.48
PRSS2 P07478 1/20 0.48
F7 P08709 1/20 0.48
F3 P13726 1/20 0.48
PRSS3 P35030 1/20 0.48
LMNA P02545 2/20 0.48
RAB9A P51151 2/20 0.47
NPC1 O15118 1/20 0.47
HTT P42858 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7659160 0.86 F10 (0.55) F10PLAUPLATSMN1; SMN2ALDH1A1
SCHEMBL7657749 0.86 F10 (0.63) F10PLAUPLATSMN1; SMN2MEN1
SCHEMBL7661905 0.85 F10 (0.58) F10PLAUPLATSMN1; SMN2ALDH1A1
SCHEMBL7659158 0.83 F10 (0.58) F10PLAUPLATSMN1; SMN2MEN1
SCHEMBL7664302 0.83 F10 (0.57) F10PLAUPLATSMN1; SMN2ALDH1A1
SCHEMBL7663545 0.81 F10 (0.59) F10PLAUPLATSMN1; SMN2ALDH1A1
SCHEMBL7663479 0.81 F10 (0.67) F10PLAUPLATSMN1; SMN2MEN1
SCHEMBL7660241 0.80 F10 (0.58) F10PLAUPLATSMN1; SMN2ALDH1A1
SCHEMBL7660257 0.79 F7 (0.51) F10PLAUPLATMEN1KMT2A
SCHEMBL7662377 0.79 F10 (0.67) F10PLAUPLATSMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6358960-B1 FOR THERAPY OF INTRAVASCULAR COAGULATION, CORONARY THROMBOSIS, CEREBRAL INFARCTION, CEREBRAL EMBOLISM, TRANSIENT ISCHEMIC ATTACK, CEREBROVASCULAR DISORDERS, PULMONARY VASCULAR DISEASES, DEEP VENOUS THROMBOSIS, ETC. ONO PHARMACEUTICAL CO., LTD. (JP) 2002-03-19 US disclosed
EP-1078917-A1 AMIDINO DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2001-02-28 EP disclosed